高级搜索

人乳头瘤病毒16型E6/E7基因shRNA真核表达载体构建及其对人宫颈癌SiHa细胞增殖及迁移能力的影响

阿比丹•吐尔汗江, 杨润峰, 王 恬, 李 莎, 栗 妍, 项 涛

阿比丹•吐尔汗江, 杨润峰, 王 恬, 李 莎, 栗 妍, 项 涛. 人乳头瘤病毒16型E6/E7基因shRNA真核表达载体构建及其对人宫颈癌SiHa细胞增殖及迁移能力的影响[J]. 肿瘤防治研究, 2014, 41(05): 392-396. DOI: 10.3971/j.issn.1000-8578.2014.05.010
引用本文: 阿比丹•吐尔汗江, 杨润峰, 王 恬, 李 莎, 栗 妍, 项 涛. 人乳头瘤病毒16型E6/E7基因shRNA真核表达载体构建及其对人宫颈癌SiHa细胞增殖及迁移能力的影响[J]. 肿瘤防治研究, 2014, 41(05): 392-396. DOI: 10.3971/j.issn.1000-8578.2014.05.010
Abidan•Tuerhanjiang, YANG Runfeng, WANG Tian, LI Sha, LI Yan, XIANG Tao. Construction of shRNA Eukaryotic Expression Vector Targeting Human Papillomavirus Type 16 E6/E7 Gene and Its Effects on Proliferation and Migration of SiHa Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 392-396. DOI: 10.3971/j.issn.1000-8578.2014.05.010
Citation: Abidan•Tuerhanjiang, YANG Runfeng, WANG Tian, LI Sha, LI Yan, XIANG Tao. Construction of shRNA Eukaryotic Expression Vector Targeting Human Papillomavirus Type 16 E6/E7 Gene and Its Effects on Proliferation and Migration of SiHa Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 392-396. DOI: 10.3971/j.issn.1000-8578.2014.05.010

人乳头瘤病毒16型E6/E7基因shRNA真核表达载体构建及其对人宫颈癌SiHa细胞增殖及迁移能力的影响

基金项目: 国家自然科学基金资助项目(81071663)
详细信息
    作者简介:

    阿比丹•吐尔汗江(1985-),女,硕士在读,主要从事宫颈癌基础研究

    通信作者:

    项涛,E-mail: xiangtao72@sina.com

  • 中图分类号: R737.33

Construction of shRNA Eukaryotic Expression Vector Targeting Human Papillomavirus Type 16 E6/E7 Gene and Its Effects on Proliferation and Migration of SiHa Cells

  • 摘要: 目的 构建针对人乳头瘤病毒16型E6/E7基因的shRNA真核表达载体,获得稳定表达干扰质粒的人宫颈癌SiHa细胞系并探讨其对SiHa细胞增殖及迁移能力的影响。方法 合成3条特异性干扰HPV16 E6/E7基因的shRNA片段并定向插入psilencer 2.1-U6 hygro载体,构建重组质粒psilencer 2.1-U6 hygro-shE6/E7并转染入人宫颈癌SiHa细胞, Real- time PCR检测转染后细胞E6/E7 mRNA的表达,选择沉默效应最好的重组质粒并用潮霉素B稳筛,获得稳定表达重组质粒的SiHa细胞,并用real time-PCR和Western blot方法进行鉴定;分别运用CCK-8细胞增殖实验和细胞划痕愈合实验检测细胞的增殖及迁移能力。结果 测序证实针对HPV16 E6/E7的shRNA真核表达载体psilencer 2.1-U6 hygro-shE6/E7 构建正确;转染psilencer 2.1-U6 hygro-shE6/E7的SiHa细胞HPV16 E6/E7表达明显受抑,同时其增殖及迁移能力也明显受抑制。结论 psilencer 2.1-U6 hygro-shE6/E7真核表达载体的成功构建并获得稳定沉默表达HPV16 E6/E7的人宫颈癌SiHa细胞系,证实沉默表达HPV16 E6/E7的SiHa细胞增殖及迁移能力会明显受到抑制,这为进一步研究HPV 16 E6/E7基因在宫颈癌发生发展过程中的功能奠定了实验基础。

     

    Abstract: Objective To construct the short hairpin RNA(shRNA) eukaryotic expressing vector targeting human papillomavirus type 16 E6/E7 to establish stable transfected SiHa cell line and to observe its effects on cell proliferation and migration. Methods Three pairs of shRNA fragments which could specifically inhibit HPV16 E6/E7 genes were synthesized and cloned into the shRNA vector psilencer2.1-U6 hygro. The recombinant vectors were transfected into SiHa cells by Lipo2000 and E6/E7 mRNA expression was validated by real-time PCR. The stable psilencer 2.1-U6 hygro-shE6/E7-SiHa cell line was selected with hygromycin B and validated by real-time PCR and Western blot.The CCK-8 cell proliferation assay and cell scratch wound healing assay were performed to examine cell proliferation and migration. Results Sequencing suggested that shRNA eukaryotic expression vector targeting HPV16 E6/E7 gene, psilencer 2.1-U6 hygro-shE6/E7-SiHa cell line, was established successfully with a signifi cantly inhibition of HPV16 E6/E7 expression, cell proliferation and migration. Conclusion Inactivation of HPV16 E6/E7 in cervical cancer cells could reduce cell proliferation and migration.

     

  • [1] Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation[J]. Nat Rev Cancer,2010,10(8):550-60.
    [2] Muñoz N, Bosch FX, de Sanjosé S,et a1.Epidemioologic classification of human papillomavirus types associated with cervical cancer [J]. N Engl J Med,2003,348(6):518-27.
    [3] McCloskey R,Menges C,Friedman A,et al.Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation. [J]. J Virol,2010,84(10):5131-9.
    [4] Hoenil Jo, Jae Weon Kim. Implications of HPV infection in uterine cervical cancer[J]. Cancer Therapy,2005,3:419-34.
    [5] McLaughlin-Drubin ME,Münger K.Oncogenic activities of human papillomaviruses[J]. Virus Res,2009,143(2):195-208.
    [6] Corusi? A, Skrgati? L, Mahovli? V,et al.Cervical cancer as a public health issue--what next? [J]. Coll Antropol, 2010, 34(1):301-7.
    [7] Woodman CB,Collins SI,Young LS.The natural history of cervical HPV infection: unresolved issues[J]. Nat Rev Cancer,2007,7(1):11-22.
    [8] Berghella V,Figueroa D,Szychowski JM,et al.17-alphahydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length[J]. Am J Obstet Gynecol,2010,202(4):351.e1-6.
    [9] Massimi P, Shai A, Lambert P,et al.HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background[J]. Oncogene,2008,27(12):1800-4.
    [10] American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Use of progesterone to reduce preterm birth[J]. Obstet Gynecol,2003,102(5 Pt 1):1115-6.
    [11] Kisseljov F, Sakharova O, Kondratjeva T. Cellular and molecular biological aspects of cervical intraepithelial neoplasia[J]. Int Rev Cell Mol Biol,2008,271:35-95.
    [12] Feng SY,Zhang YN,Liu JG.Risk factors and prognosis of nodepositive cervical carcinoma[J].Ai Zheng,2005,24(10):1261-6. [冯 淑瑜,张彦娜,刘建刚.宫颈癌淋巴结转移的高危因素及预后分 析[J] 癌症,2005,24(10):1261-6.]
    [13] Hellner K,Mar J,Fang F,et al.HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition[J].Virology,2009,391 (1):57-63.
计量
  • 文章访问数:  1681
  • HTML全文浏览量:  466
  • PDF下载量:  717
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-04-04
  • 修回日期:  2013-07-23
  • 刊出日期:  2014-05-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭